Branded

SAN ANTONIO — Mission Pharmacal Co. has announced the launch of prescription-only Aquoral, a dry-mouth relief oral spray that promises to moisten and lubricate the mouth for up to four hours.

NEW YORK — WebMD Health on Monday announced the availability of the WebMD Cold and Flu Symptoms Across the Nation map and companion health center to help consumers stay ahead of cold and flu symptoms this season.  

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug made by Actelion Pharmaceuticals for treating pulmonary arterial hypertension.

The agency announced the approval of Opsumit (macitentan) for adults with PAH, a chronic, progressive and debilitating disease caused by high blood pressure in the arteries that connect the heart to the lungs that can lead to death or the need for lung transplantation.

WASHINGTON — Nearly 1-in-50 people in the United States are at risk of severe allergic reactions, according to a new study announced Monday by the Asthma and Allergy Foundation of America.

According to the study, severe, life-threatening allergic reactions known as anaphylaxis are common in the United States, occurring in about 1.6% of the population. The rate, the study said, is probably higher, and closer to 5.1%. The study was published in the Journal of Allergy and Clinical Immunology.

WHIPPANY, N.J. — Bayer HealthCare last week moved into its new U.S. headquarters on a 94-acre campus here, consolidating Bayer HealthCare's operations that previously operated from Morristown, Montville and Wayne, N.J., and Tarrytown, N.Y., into one location.  

Housed in two buildings connected by a five-story glass atrium, the 700,000-sq.-ft. office space features state-of-the-art technology and a modern open design for the approximately 2,400 employees now based at the new location.

FRAMINGHAM, Mass. — Nearly 90% of office workers come to work even when they know they are sick, according to the fourth annual Flu Season Survey from Staples. The findings show a growing trend when compared to last year’s findings indicating 80% of workers come to work sick, and up from 60% in the 2011 Staples survey.

PHILADELPHIA — The Food and Drug Administration has approved a pain drug made by Iroko Pharmaceuticals, Iroko said.

The drug maker announced the approval of Zorvolex (diclofenac) capsules for mild to moderate acute pain in adults. The drug is a non-steroidal anti-inflammatory drug, or NSAID, belonging to the same class as the common analgesic drug ibuprofen. Zorvolex was approved at dosage strengths 20% lower than currently available diclofenac products, the company said.

ATLANTA — The Food and Drug Administration has approved a drug made by UCB for treating a form of arthritis.

The drug maker said Friday that the FDA had approved Cimzia (certolizumab pegol) for adults with active ankylosing spondylitis, though it declined to approve the drug for axial spondyloarthritis, or axSpA. UCB said it was working with the agency to determine how to get the drug approved for axSpA.